EBOS Group Limited (NZE:EBO)

Market Cap	7.73B
Revenue (ttm)	13.92B
Net Income (ttm)	271.67M
Shares Out	203.23M
EPS (ttm)	1.40
PE Ratio	27.08
Forward PE	23.94
Dividend	1.22 (3.30%)
Ex-Dividend Date	Feb 27, 2025

Volume	172,422
Average Volume	2,903,534
Open	38.09
Previous Close	38.05
Day's Range	37.87 - 38.18
52-Week Range	31.02 - 42.55
Beta	0.26
RSI	48.23
Earnings Date	May 20, 2025

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1922
• Employees: 4,963
• Stock Exchange: New Zealand Stock Exchange
• Ticker Symbol: EBO

Financial Performance

In 2024, EBOS Group's revenue was 13.19 billion, an increase of 7.78% compared to the previous year's 12.24 billion. Earnings were 271.55 million, an increase of 7.17%.

Financial numbers in AUD